Fischer Medical Ventures Ltd. (FISCHER.NS) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

+95.9%

₹48.62

vs ₹24.82 price

Levered DCF

-₹496.39

After debt service

Piotroski score

2 / 9

Weak

Altman Z-score

—

Rating

C-

Overall 1 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
P/E	84.19×	9,697.5×	456.35×	-369.43×	-57.47×	94.61×	-323.25×	2,938.64×
P/B	6.83×	33.38×	10.64×	-50.16×	-58.14×	4,304.44×	-96.85×	-138.32×
P/S	8.52×	101.77×	41.13×	74.34×	0×	80.87×	72.42×	69.32×
EV / EBITDA	63.26×	2,651.83×	365.85×	950.75×	-72.69×	-74.11×	0×	0×
Gross margin	30.8%	17.3%	21.6%	100.0%	0.0%	51.8%	51.6%	89.5%
Operating margin	13.0%	2.8%	8.0%	8.5%	0.0%	51.8%	44.4%	82.1%
Net margin	10.1%	1.1%	8.8%	-20.3%	0.0%	85.2%	-22.3%	2.4%
Current ratio	1.6×	3.59×	18.37×	5.19×	0.12×	4.37×	2.33×	15.18×
Debt / equity	0.28×	0.25×	0.02×	-4.3×	-1.7×	75.1×	-1.57×	-2.07×
Interest coverage	6.87×	7.6×	24.82×	0.93×	-21.7×	4.74×	0×	0×
Dividend yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.9%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Return on equity	8.1%	0.4%	2.3%	13.7%	101.4%	4535.5%	29.8%	-4.7%
Return on invested capital	5.4%	0.4%	1.8%	1.7%	-118.2%	36.2%	103.8%	122.9%
Return on assets	4.6%	0.3%	2.1%	-10.3%	-122.2%	55.4%	-29.8%	4.1%
Free cash flow yield	-4.9%	-0.8%	-0.9%	-1.1%	-1.3%	-0.4%	0.1%	0.0%
Earnings yield	1.2%	0.0%	0.2%	-0.3%	-1.7%	1.1%	-0.3%	0.0%
Enterprise value	₹27.3B	₹112.5B	₹8.6B	₹144.5M	₹137.2M	₹135.3M	₹134.3M	₹134.5M
Net debt / EBITDA	2.21×	-4.45×	0.31×	72.87×	-1.98×	-1.03×	0×	0×
Cash conversion cycle (days)	194	205	456	247	0	-16	-116	0